Acute to Chronic Pain Signatures

Program Snapshot

This program will develop a set of objective biomarkers that provide a “signature” to predict a transition from acute to chronic pain, in order to accelerate therapy development and ultimately to guide pain prevention strategies. These biomarkers are greatly needed as the number of people who transition from acute to chronic pain after an acute pain event is surprisingly high. This high prevalence of chronic pain in the US has in part contributed to the current opioid epidemic.

This page last reviewed on April 10, 2019